Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Stephan Fellner(University of Regensburg), Gert Fricker(Heidelberg University), Martina Fankhänel(University of Regensburg), Thilo Spruß(University of Regensburg), David S. Miller, Claudia Graeff(Heidelberg University), Harald Gschaidmeier(Novartis (Germany)), Günther Bernhardt(University of Regensburg), Björn Bauer(University of Minnesota), Armin Buschauer(University of Regensburg), Lothar Färber(Novartis (Germany)), Martina Schaffrik(University of Regensburg)
Cited by 360
Related Papers
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
|Journal of Clinical Investigation|2002|345
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
|Pharmaceutical Research|2010|325